Caprolactam Chemicals Ltd (507486)
Latest quarterly results (Q1 FY27)
In its latest reported quarter, Q1 FY27, Caprolactam Chemicals' revenue was ₹0.5 Cr (-81.7% year on year, -84.8% on the previous quarter), and net profit ₹-1.0 Cr (against a profit a year earlier); the operating margin was -95.1%.
| Q1 FY27 (₹ Cr) | Value | YoY vs Q1 FY26 | QoQ |
|---|---|---|---|
| Revenue | ₹0.5 | -81.7% | -84.8% |
| Operating profit | ₹-0.4 | to loss | to loss |
| Net profit | ₹-1.0 | to loss | to loss |
| EPS (₹) | -2.15 | to loss | to loss |
| Operating margin | -95.1% | — | — |
📢 Recent Corporate Announcements
Caprolactam Chemicals Limited held a board meeting on August 31, 2026, recommending the appointment of M/s. Raman S. Shah & Co as Statutory Auditors for a 5-year term from the 37th AGM to the 42nd AGM. The proposed statutory audit fee is Rs 1,10,000 plus taxes, subject to shareholder approval. The company also fixed its 37th AGM date for September 28, 2026, with a cut-off date of September 21, 2026 for e-voting.
- Recommended appointment of M/s. Raman S. Shah & Co (FRN: 111919W) as Statutory Auditors until 42nd AGM
- Proposed annual statutory audit fee fixed at Rs 1,10,000 plus applicable taxes
- 37th AGM scheduled for September 28, 2026 at 10:30 AM
- Cut-off date for e-voting entitlement set as September 21, 2026
- E-voting period runs from September 24, 2026 to September 27, 2026
Caprolactam Chemicals Ltd reported a severe downturn in its Q1 FY27 results, with revenue from operations plunging 81.7% YoY to just Rs 46.77 Lakhs. The company swung to a net loss of Rs 98.86 Lakhs for the quarter, compared to a profit of Rs 36.35 Lakhs in the same period last year. Total expenses of Rs 145.74 Lakhs significantly outpaced total income, driven by fixed costs like depreciation (Rs 36.71 Lakhs) and finance costs (Rs 17.76 Lakhs) which did not scale down with revenue. This performance represents a sharp reversal from the profitable FY26 trend.
- Revenue from operations fell 81.7% YoY to Rs 46.77 Lakhs from Rs 256.47 Lakhs.
- Net loss of Rs 98.86 Lakhs recorded against a profit of Rs 36.35 Lakhs in Q1 FY26.
- Quarterly revenue represents only ~4.3% of the company's TTM revenue of Rs 11 Cr.
- Earnings Per Share (EPS) dropped to -2.15 from 0.79 in the year-ago quarter.
- Finance costs remained high at Rs 17.76 Lakhs, nearly 38% of the total quarterly revenue.
Caprolactam Chemicals Ltd has scheduled a board meeting on August 13, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026. This follows a significant turnaround in FY26, where the company reported a net profit of ‡1.76 cr compared to a loss of ‡0.71 cr in FY25. The company currently operates on a small scale with TTM revenue of ‡11 cr and a market capitalization of ‡22 cr. The trading window for insiders has been closed since July 1, 2026, as per regulatory requirements.
- Board meeting date set for August 13, 2026, to review Q1 FY27 performance
- Trading window for securities closed from July 1, 2026, until 48 hours post-announcement
- Company reported a high TTM Operating Profit Margin (OPM) of 42.4%
- Market capitalization is currently ‡22 cr, placing it in the micro-cap category
- Debt-to-Equity ratio stands at 1.40 with ‡9 cr in total debt
Financial Performance
Financial analysis data not yet available for this company.
Operational Drivers
Operational analysis data not yet available for this company.
Strategic Growth
Strategic growth analysis not yet available for this company.
External Factors
External factors analysis not yet available for this company.
Regulatory & Governance
Regulatory analysis not yet available for this company.
Risk Analysis
Risk analysis not yet available for this company.
